(Q39686642)

14 September 2017

title

Risk behaviours and benign prostatic hyperplasia (English)

1 reference

14 September 2017

9

1 reference

14 September 2017

1

Kang D

1 reference

14 September 2017

Andriole GL

2

1 reference

14 September 2017

Van De Vooren RC

3

1 reference

14 September 2017

Crawford D

4

1 reference

14 September 2017

Chia D

5

1 reference

14 September 2017

Urban DA

6

1 reference

14 September 2017

Reding D

7

1 reference

14 September 2017

Huang WY

8

1 reference

14 September 2017

publication date

1 June 2004

1 reference

14 September 2017

1 reference

14 September 2017

volume

93

1 reference

14 September 2017

issue

9

1 reference

14 September 2017

page(s)

1241-1245

1 reference

Benign prostatic hyperplasia: an overview

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Trends in prostatectomy for benign prostatic hyperplasia among black and white men in the United States: 1980 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

The epidemiology of benign prostatic hyperplasia: a study in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Benign prostatic hyperplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Relationship of demographic and clinical factors to free and total prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Association between cigarette smoking and prostatism in a Japanese community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Predictors of sex hormone levels among the elderly: a study in Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Is there an association between cigarette smoking and gland size in benign prostatic hyperplasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Contrasting effects of aspirin on prostate cancer cells: suppression of proliferation and induction of drug resistance .

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

Cigarette smoking and prostatism: A biphasic association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04839.X

10.1111/J.1464-410X.2004.04839.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference